Dr.
Labège, France
Dr.
Labège, France

Time filter

Source Type

News Article | March 1, 2017
Site: www.prweb.com

Breast Surgeon, Dr. Dennis Holmes of 90210 Surgery Medical Center will review minimally invasive cryoablation for the treatment of early stage breast cancer and where it fits in the treatment paradigm at Susan G. Komen San Diego’s Annual Dinner Symposium, “Screens, Genes & The Choices We Make.” The event brings together leading cancer and wellness experts to share the latest innovations in breast cancer research, treatment and holistic well-being. The symposium will take place on Thursday, March 16, 2017 at the San Diego Del Mar Marriott. Dr. Holmes is an internationally renowned breast surgeon and cancer researcher currently serving as Interim Director of the Margie Petersen Breast Center at Providence St. John’s Health Center and Interim Director, John Wayne Cancer Institute Breast Surgery Fellowship Program. Formerly, Dr. Holmes held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Women’s Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California Kenneth Norris Comprehensive Cancer Center. Dr. Holmes has been a pioneer in the field of minimally invasive breast surgery, including intraoperative radiotherapy, lymph node-sparing surgery and cryoablation “I am thrilled to partner with Komen San Diego, as we share similar goals - to save lives and pursue the best breast cancer treatments,” said Dr. Holmes. Currently, the standard of care for early stage breast cancer is surgery (e.g. lumpectomy, mastectomy) and sentinel node biopsy followed by breast radiotherapy and adjuvant endocrine and/or chemotherapy. Although surgery offers tumor removal and margin verification, a major drawback of surgery is the cosmetic and functional impairment of the breast resulting from volume changes, scar formation, nipple displacement, sensation changes, skin/scar retraction, and re-excision rate. Dr. Holmes was an investigator in the National Cancer Institute Z1072 Clinical Trial sponsored by the Alliance for Clinical Trials in Oncology. The trial examined cryoablation for the treatment of early stage breast cancer. In a 5-year multicenter study, cryoablation was shown to be 92% effective for complete ablation of invasive breast tumors ≤2 cm and 100% effective for complete ablation of invasive ductal breast cancer tumors <1.0 cm. Results from this breast cancer study (ACOSOG Z1072), which included a 5-year follow-up, were published in the Annals of Surgical Oncology. The Visica® 2 Treatment System developed by Sanarus Technologies, was the exclusive device used in the Z1072 study. “Cryoablation is a very promising alternative to traditional surgery for early stage breast cancer. Cryoablation minimizes changes in breast volume and nipple position, and avoids prominent scars,” explained Dr. Holmes. “The outstanding results of Z0172 inspired me to start the FROST Clinical Study, for which I now serve as Principal Investigator.” The FROST Clinical Study is the evolution of data from Z1072, which examines the rate of successful tumor ablation in patients treated with cryoablation of the primary tumor instead of surgical removal of early stage breast cancer. The FROST Clinical Study is currently enrolling women age 50 and older with core needle biopsy proven clinical stage I, T1, (≤1.5 cm) clinically node negative (N0), unifocal, hormone receptor positive and HER2/neu-negative invasive ductal carcinoma. Cryoablation with the Visica 2 Treatment System is a nonsurgical option for patients that have been diagnosed with early stage breast cancer, is visible on sonogram, and has been confirmed with a biopsy. This procedure has many benefits including: under 30-minutes, local anesthesia, in-office, excellent cosmesis, cost efficient, and quick patient recovery. Cryoablation is a viable option to surgery that results in complete early stage tumor ablation. About Dr. Holmes Dr. Holmes serves in the leadership of several national surgical societies and is a frequent lecturer at national conferences. He is a member of the education committee of the American Society of Breast Surgeons. Dr. Holmes is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes has gained worldwide acclaim for his pioneering research in targeted intraoperative radiotherapy. Dr. Holmes believes wholeheartedly that, with proper treatment, most women diagnosed with breast cancer will live a long, fulfilling life—a life both richer and more meaningful than they could have ever imagined. Find out more at http://www.drholmesmd.com About Sanarus Technologies In 2001, the Visica® 2 Treatment System was the first device available for cryoablation of fibroadenomas. Since then, our system has been used to successfully treat thousands of patients. The Visica 2 Treatment System is FDA-cleared for the ablation of cancerous or malignant tissue and benign tumors. At Sanarus, we develop innovative solutions for the nonsurgical treatment of breast tumors. We are headquartered in Pleasanton, CA, and all our products are manufactured in the USA. Find out more at http://www.sanarus.com ABOUT SUSAN G. KOMEN SAN DIEGO®: Since its inception in 1995, Komen San Diego has granted more than $18 million to research and local non-profits who provide everything from free diagnostic mammograms, meal delivery, temporary financial aid, transportation and more. Seventy-five percent of every dollar raised in San Diego stays in San Diego County to fund breast health services for uninsured and underinsured women and their families. The remaining 25 percent funds international breast cancer research. In fact, next to the U.S. government, Susan G. Komen® is the largest funder of breast cancer research in the world. For more information, please visit http://www.komensandiego.org. Connect with us on Facebook and Twitter and Instagram.


News Article | February 15, 2017
Site: www.prweb.com

Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC in Atlanta was recently recognized by Find Local Doctors as a Top Patient Rated Facial Plastic Surgeon for 2017. This honor is one of numerous awards and achievements that Dr. Stong has earned as a leading facial plastic surgeon in Atlanta. Find Local Doctors is an online directory that helps consumers find the most qualified and reputable physicians in their area. The Top Patient Rated Plastic Surgeon award is an acknowledgement that Dr. Stong has garnered five star ratings and excellent online reviews from his patients across multiple sources. His patients posted impressive remarks about their positive experience at Kalos Facial Plastic Surgery as well as their natural-looking and youthful results in advanced cosmetic procedures. Dr. Stong is dual board certified in Otolaryngology Head and Neck Surgery and Facial Plastic and Reconstructive Surgery by the American Board of Otolaryngology and the American Board of Facial Plastic and Reconstructive Surgery (ABFPRS). These distinguished credentials means that he brings the highest level of specialization, education, and certification in Facial Plastic and Reconstructive surgery. Dr. Stong has earned a strong reputation for his advanced techniques in facelifts, rhinoplasty and blepharoplasty. He also offers an expansive menu of non-surgical services in facial rejuvenation, ranging from bruise-free facial fillers and microneedling to laser treatments and highly advanced stem-cell facelifts. Dr. Stong offers his services in a state-of-the-art facility in Atlanta, where patient-centered care is paramount. Dr. Stong is committed to creating the most natural and balanced results by using innovative and proven techniques in plastic surgery. His methods include ways to improve patient comfort, minimize downtime and promote longer lasting results. He is one of the few plastic surgeons in the country to offer the deep plane facelift and the first in Atlanta to offer the extended deep plane facelift. With this facelift technique, patients can benefit from faster recovery time and the most natural-looking improvements within the neck, jawline and cheeks. “My success as a plastic surgeon is always determined by the satisfaction of my patients. Knowing my patients are pleased with their aesthetic results is the highest honor I could receive,” says Dr. Stong. Owner and facial plastic surgeon, Dr. Benjamin Stong is dual board certified in Head and Neck Surgery and Facial Plastic and Reconstructive Surgery. He completed his fellowship under one of the most nationally renowned plastic surgeons, Dr. Andrew Jacono in New York. He combines his reputable level of training with his own proven experience and talent to bring patients of Atlanta outstanding results in plastic surgery. Among his previous achievements are his consecutive wins as a "Top Doctor" by Castle Connolly. This is a highly respected recognition that is based on peer nomination and extensive review. Kalos Facial Plastic and Reconstructive Surgery specializes in providing the most advanced techniques in facial plastic surgery and other cosmetic services. If you would like to get more information about the services offered by Kalos Facial Plastic Surgery, LLC, please call their Atlanta office at (404) 963-6665 or visit their website at kalos-plasticsurgery.com.


News Article | February 15, 2017
Site: www.prweb.com

During pregnancy, women are at an increased risk of dental problems ranging from gum disease to enamel erosion, and those dental problems can increase the risk of pregnancy complications. Unfortunately, according to research from the Massachusetts Department of Public Health, many pregnant women are failing to get the dental care they need. Agoura Hills dentist, Philip Shindler DDS, comments on this new research about dental care during pregnancy. According to the study, about fifty percent of pregnant women scheduled routine dental cleanings during their pregnancies. For many years, a myth has persisted that dentistry is not safe for pregnant women, and this has kept them from getting the care they need. Although patients do need to notify Dr. Shindler of their pregnancy status at their appointments, it can be helpful if they do. He can take any necessary precautions while still providing them with essential treatments. “During pregnancy, the risk of pregnancy-related dental issues increases as a result of morning sickness, increased blood flow, gastric reflux, and heightened sensitivity to oral bacteria,” comments Dr. Shindler. A different study performed in 2011 linked periodontitis, or gum disease, to low birth weights, preterm labor, and miscarriage. Inflammation is linked to bacterial vaginosis, which is also linked to pregnancy complications. The American College of Obstetrics and Gynecology has stated that dental care is safe and effective during pregnancy, including: Delaying these treatments can lead to a worsened condition and increased risks to the pregnancy. Dr. Shindler graduated from WITS University in Johannesburg, South Africa, and completed a postgraduate program at the University of California, Los Angeles. He is certified through Nobel Biocare in dental implants restoration, and has completed other advanced programs in order to provide his patients with the latest options. Today, Dr. Shindler is a member of the Conejo Valley Academy, the American Dental Association, and the California Dental Association. He offers extensive treatment options, including CariFree, porcelain veneers, dental implant restorations, Kors whitening treatments, inlays and onlays, dental bridges, dentures, and dental crowns.


News Article | February 15, 2017
Site: www.prweb.com

Wiseman Endodontics, formerly of San Diego, California, will now provide the Sioux Falls area with modern endodontic services backed by the latest technology and delivered in a friendly, accessible manner. The practice will open in March. Referrals are extensions of a dental practice. When general dentists send patients to a specialist, they expect the patients to receive a similar level of care. Patients visiting a specialist can experience heightened anxiety. It’s vital that a specialist takes the time to answer any and all questions, remains approachable and makes every patient comfortable. “I am an oral surgeon and have worked closely with Dr. Wiseman, who has done a marvelous job helping patients who need endodontic care,” says Stephen L. Wheeler, DDS. “In fact, our office manager was treated by Dr. Wiseman and could not say enough wonderful things about the professional care received at her office.” General dentists also expect a specialist to communicate well with their own practices. Wiseman Endodontics makes communication with referring dentists a priority. “We thoroughly enjoyed working with Dr. Wiseman,” says Sean Hariri, DDS. “Her level of communication and correspondence regarding cases was always constant and complete.” Wiseman Endodontics employs the latest technology available for the best possible care: Dr. Anne Wiseman, DDS, is a Diplomate of the American Board of Endodontics. She has practiced in the San Diego area for the last few years. In addition to completing an endodontic residency and implant surgery fellowship, Dr. Wiseman also served a three-year tour of duty in the United States Navy.


News Article | February 28, 2017
Site: www.prweb.com

Agoura Hills dentist, Dr. Philip Shindler, is offering a limited time promotion on Invisalign. Invisalign’s orthodontic system has quickly become one of the most popular ways for teens and adults to achieve their best smiles. It uses clear trays to shift the position of each tooth. The trays are comfortable and nearly invisible, making treatment more subtle and discreet. Invisalign can treat orthodontic problems such as overbites, underbites, crossbites, and spacing issues. The special promotion includes $500 off Invisalign. Dr. Shindler offers a variety of Invisalign treatment options, including: 1.    Invisalign Classic Invisalign is the ideal solution for most orthodontic problems, including crossbite, overbite, underbite, gaps, crowding, and crooked teeth. Most people who are candidates for braces are also candidates for Invisalign, but patients will need to visit an Invisalign dentist such as Dr. Philip Shindler to determine their candidacy. 2.    Invisalign Express Patients with minor orthodontic problems or orthodontic relapse, or who are candidates for smile makeovers may benefit from Invisalign Express. Invisalign Express is a streamlined version of Invisalign designed to work quickly and efficiently often in just six months. 3.    Invisalign Teen Younger patients have special orthodontic needs that are often best addressed through Invisalign Teen. Invisalign Teen features eruption tabs, which accommodate erupting teeth, and Blue Dot indicators, which remind them to wear and change their aligners on schedule. Invisalign may be covered by dental insurance plan and might be reimbursed through flexible savings accounts. Special financing options are also available. Dr. Shindler also offers other treatments, including porcelain veneers, dental implant restorations, dental crowns and bridges, CariFree, teeth whitening, dental cleanings, and bruxism mouth guards. Dr. Shindler is a member of the Alpha Omega Dental Society, the Conejo Valley Academy, the California Dental Association, and the American Dental Association. A graduate of WITS University in Johannesburg, South Africa, Dr. Shindler completed a postgraduate program at UCLA after immigrating to California in 1981. He is certified to restore dental implants by Nobel Biocare, and he volunteers at Wildlife Waystation performing animal dentistry.


News Article | February 16, 2017
Site: www.eurekalert.org

Does the biological clock in cancer cells influence tumour growth? Yes, according to a study conducted by Nicolas Cermakian, a professor in McGill University's Department of Psychiatry. Published in the journal BMC Biology, these results show for the first time that directly targeting the biological clock in a cancerous tumour has an impact on its development. Most of the cells in the human body have an internal clock that sets a rhythm for the activities of our organs according to the time of the day. Cancer cells, however, often have a non-functioning or malfunctioning clock. "There were indications suggesting that the malfunctioning clock contributed to rapid tumour growth, but this had never been demonstrated. Thanks to the use of a chemical or a thermic treatment, we succeeded in 'repairing' these cells' clock and restoring it to its normal functioning. In these conditions, tumour growth drops nearly in half", explains Cermakian, who is also Director of the Laboratory of Molecular Chronobiology at the Douglas Mental Health University Institute, one of the research centres of the CIUSSS de l'Ouest-de-l'Île-de-Montréal. Although this preclinical demonstration was done on mice, this important discovery provides a glimpse of potential new ways to treat cancer in humans. "Activating the biological clock in tumours could become an innovative approach in slowing their growth or that of metastases. This would give people more time to use more conventional treatment modalities, such as surgery or chemotherapy", says Cermakian. It now remains to be shown that we can target the clocks in human tumours the same way." For this study, Silke Kiessling, a postdoctoral fellow on Nicolas Cermakian's team, successfully adjusted the gears of the internal clocks in two types of cancer cells ? skin and colon ? to make them function properly. This repair, which was tested in mice and tissue cultures, slowed cancerous tumour growth. After about a week, the tumour treated in this manner was two-thirds smaller than the control tumour. While it is difficult to say at this point what types of cancer might be amenable to such an approach, this new concept could lead to an improvement in human cancer treatment in the long term, the researchers say. This research was funded by the Canadian Institutes of Health Research (CIHR) and the Fonds de la recherche du Québec-Santé (FRQ-S). The article "Enhancing circadian clock function in cancer cells inhibits tumor growth" was published in the journal BMC Biology on February 14, 2017. DOI: 10.1186/s12915-017-0349-7 Nicolas Cermakian (PhD) is the director of the Laboratory of Molecular Chronobiology at the Douglas Mental Health University Institute and a Full Professor at McGill University's Department of Psychiatry. He is currently the president of the Canadian Society for Chronobiology. The work done in his laboratory focuses on maximizing our understanding of "the gears in the biological clock" and their impacts on physiology. He also studies the consequences of dysfunctional clocks on health including psychiatric disorders, infectious diseases and cancer. Silke Kiessling worked as a postdoctoral fellow in the team of Dr. Cermakian. She is currently a researcher at the Technical University of Munich. The Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal is made up of the CSSS de l'Ouest-de-l'Île, the CSSS de Dorval-Lachine-LaSalle, St. Mary's Hospital, St. Anne's Hospital, Douglas Mental Health University Institute, West Montreal Readaptation Centre, Grace Dart Extended Care Centre, and Batshaw Youth and Family Centres. The Douglas Mental Health University Institute is a world-class institute affiliated with McGill University and the World Health Organization. It treats people suffering from mental illness and offers them both hope and healing. Its teams of specialists and researchers are constantly increasing scientific knowledge, integrating this knowledge into patient care, and sharing it with the community in order to educate the public and eliminate prejudices surrounding mental health.


News Article | February 21, 2017
Site: www.prweb.com

Dr. Harold Katz, creator of the bad breath fighting TheraBreath Oral Rinse, is excited to announce the launch of a new oral rinse developed just for kids. “TheraBreath has been helping adults who struggle with bad breath for years. Our oral rinses freshen breath without the use of problematic ingredients found in most mass-produced mouthwashes,” said Dr. Katz. “We really felt that it was time for kids to have access to the same level of oral rinse — one that tastes great, fights cavities, and is free of artificial dyes and flavors.” The result is TheraBreath for Kids! Anti Cavity Oral Rinse. Made from organically grown grapes and sweetened with Xylitol, the children’s oral rinse is made only in small batches, allowing it to contain fewer preservatives and no dyes or artificial additives. The children’s anti cavity oral rinse, available online at http://www.TheraBreath.com and at Wal-Mart stores nationwide, is perfectly timed to align with Children’s Oral Health Month. The American Dental Association (ADA) identifies February as a month to focus on children’s oral health and ways to reduce cavities and improve the condition of children’s teeth. This year the organization is asking parents to focus on encouraging their children to consume more tap water and make good oral hygiene choices. About Dr. Katz, Founder of TheraBreath® Dr. Harold Katz is the recognized expert in the fields of bad breath, dry mouth, and tonsil stones. Known as the “Bad Breath Guru” from his numerous appearances on shows like “The View” and the CBS “Early Show,” he has helped millions of people around the world eliminate their bad breath problems. He is a graduate of UCLA and the UCLA School of Dentistry and has a degree in Bacteriology, also from UCLA. About TheraBreath® Since the introduction of TheraBreath® products in 1994, Dr. Katz has helped millions of people in 98 countries fight bad breath through the use of the TheraBreath® System formulas, which help maintain truly fresh breath and allow users to gain newfound self-confidence. TheraBreath® is the world’s top premium oral care system and has offices in Los Angeles, California. To learn more, visit http://www.therabreath.com.


News Article | February 15, 2017
Site: www.prweb.com

The Centers for Disease Control and Prevention (CDC, 2016), report one in four Americans have more than two chronic conditions or multiple chronic conditions (MCC) and 93% of Medicare funding is spent on patients with MCC’s. Symptomatic MCCs require the integration of palliative care – or symptom management. Palliative care promotes a comprehensive, coordinated, interdisciplinary and evidence based approach to meet the individual needs of the patient and family. Effective symptom management with attention to the emotional, social and spiritual needs of the patient promote quality of life. The Integration of Palliative Care in Chronic Conditions: An Interdisciplinary Approach, provides all health care professionals with the tools to meet the demands of the largest, fastest growing and costliest US patient population – those with MCCs. This textbook reviews the current trends in health policy and practice and directs health care teams on the implementation of best practices. Optimal patient-centered outcomes are used to demonstrate quality in our value-driven health care system. “The purpose of Integration of Palliative Care in Chronic Conditions: An Interdisciplinary Approach is to provide interdisciplinary healthcare teams with a road map to ensure best practices in the care and management of the largest, fastest growing, and costliest US patient population – those with multiple chronic conditions,” says Dr. Kim Kuebler, Director of the Multiple Chronic Conditions Resource Center. About Dr. Kim Kuebler and Multiple Chronic Conditions: Dr. Kim Kuebler is the Director of the Multiple Chronic Conditions Resource Center and is an award-winning author of multiple textbooks covering chronic symptomatic disease and palliative care. She has made extensive contributions to the literature and participates in editorial peer review for several medical and nursing journals. Multiple Chronic Conditions Resource Center is an interdisciplinary source for clinical practice updates, guidelines, blogs, and courses used to support best practices in the care and management of America's largest patient population - those with two or more chronic conditions. The Center is recognized by the US Department of Health and Human Services as a clinical resource for interdisciplinary health care professional's providing care for patients with Multiple Chronic Conditions. Please visit multiplechronicconditions.org or email DrKimKuebler(at)MultipleChronicConditions(dot)org.


News Article | February 15, 2017
Site: www.prweb.com

The results from the American Cancer Society’s newest report on cancer rates is good news for everyone and particularly good news for prostate cancer patients: incidents of cancer is down as is the likelihood of prostate cancer patients dying from the diagnosis. According to the report the cancer death rate has dropped from its peak of 215.1 in 1991 to 161.2 in 2014 (per 100K population), the most recent year for which data was available to analyze. Overall the decline in cancer is linked with decreases in smoking and advances in early detection and treatment. The four major cancer drops are: “This is really exciting news for anyone who specializes in prostate cancer,” says Michael Lazar, M.D. “And its particularly good news for our patients. When a man is diagnosed with cancer, whether it’s prostate cancer or some other cancer – the news is always difficult to accept. With the number of people being diagnosed with prostate cancer dropping steadily along with the expected death rates, patients are now more empowered to be optimistic about their treatment options.” According to the American Cancer Society, the decline in new cancer rates for men can be attributed to the recent drop in prostate cancer diagnoses. This has to do with the fact that routine screening with the PSA blood test is no longer recommended out of concerns for over-diagnosis and treatment of positive results that are best left untreated. Therefore, fewer cases of prostate cancer are now being detected. But this does not need to lessen the importance of getting screened for prostate cancer when symptoms are apparent. “Although this is really good news, men who are concerned about prostate cancer, and anyone in the high-risk group still needs to be to screened early and at regular intervals,” says Dr. Lazar. “Once cancer has advanced beyond the prostate gland, available treatment options become more radical.” The highest risk groups for prostate cancer are men over the age of 50, African-American men, and men who have a father, brother or son who has had prostate cancer. Most prostate cancers tend to grow slowly, and don’t cause obvious health problems for men who have received a diagnosis. In certain situations, prostate cancer can be managed conservatively, especially in elderly men. But one treatment that stands out among more invasive options for prostate cancer is High-intensity focused ultrasound (HIFU) and it is most effective for men who have been diagnose and are in the early stages of the disease. Therefore, this is one technology that requires vigilance at the early stages when HIFU would be most effective for prostate cancer eradication. “For patients with prostate cancer, HIFU treatment is most effective in the early stages,” explains Dr. Lazar. “When the cancer is localized to the prostate treatment by HIFU is extremely effective. Unlike other treatments, this procedure preserves healthy tissue and nerves, so urine flow and erectile function is maintained in a high percent of cases, as compared to radical surgery or radiation.” The oncological results for HIFU is comparable to more traditional prostate cancer treatments including radical surgery or radiation. But the side effects for HIFU patients have proven to be much less debilitating than more radical procedures. Dr. Michael Lazar is the only Northern California physician recognized as a leader in the use of high-intensity focused ultrasound (HIFU) for prostate cancer. He has been successfully treating patients with HIFU since 2007. Dr. Lazar formed California HIFU to offer minimally invasive prostate cancer treatment to men with the Sonablate. For more information about HIFU treatment which is now available in San Francisco, or to make an appointment call: (707) 546-5553. Visit us online to learn more.


News Article | February 15, 2017
Site: www.prweb.com

Top cosmetic and periodontal dentist Dr. Mahnaz Rashti announced today the launch of Smiling Patriot, a local initiative that will provide homeless veterans with potentially life-changing dental care at her practice in Beverly Hills, California. To start, Dr. Rashti will donate 20 percent of all patient payments toward providing 100 percent free dental care to veterans in need. “We are incredibly excited to officially launch Smiling Patriot,” says Dr. Rashti. “Los Angeles has one of the largest homeless populations in the country, with veterans making up as much as 11 percent of that group. By providing these individuals with the appropriate dental care, our hope is to not only improve their health, but also their confidence when pursuing jobs.” No stranger to working with veterans, Dr. Rashti spent five years training and a decade teaching at the West Los Angeles Veteran Administration Hospital. In addition, she specializes in working with phobic patients who may be particularly sensitive to the perceived trauma or psychological pressure of many dental procedures. Offering a range of services, from sedation dentistry to laser dentistry, Dr. Rashti is able to ensure the highest level of patient comfort, care, and results. “These men and women have served us proudly, and now it is our turn to serve them,” says Dr. Rashti. “A full, bright, and healthy-looking smile can have a tremendous impact on a person’s quality of life. By helping our local veterans, we are not only benefitting them as individuals, but also our community, both of which I am extremely passionate about.” Knowing that most veterans must be considered 100 percent disabled to qualify for dental coverage, Dr. Rashti founded Smiling Patriot to help close the gap. From dental implants to full mouth reconstructions, Dr. Rashti is dedicated to providing a complete spectrum of general, cosmetic, and periodontal dental services to veterans in need. For more information or to schedule an appointment with Dr. Rashti and begin benefitting veterans today, please visit https://www.dentalimplant90210.com/ or call (310) 623-3330. Dr. Mahnaz Rashti is a top Beverly Hills cosmetic and periodontal dentist with more than two decades of experience and education. She specializes in a full spectrum of general, cosmetic, and periodontal treatments, including periodontal plastic surgery, full mouth reconstruction, bone regeneration and grafting, dental implants, lip repositioning, laser dentistry, and much more. From a patient’s first exam to their final follow-up, Dr. Rashti is present and hands-on at every step of the treatment process. In placing a strong focus on patient education, Dr. Rashti and her team are pioneering a new era of dentistry, where patients have greater understanding of their treatment plans and more reliable expectations of their results. She is the recipient of several prestigious awards, including Best of Beverly Hills, Best of LA, and Best Periodontist from the American Academy of Dental Sciences.

Loading Dr. collaborators
Loading Dr. collaborators